JH

Julian Harris

Chairman & CEO at ConcertoCare / Operating Partner, Deerfield

New York City Metropolitan Area

Investor
VC
CEO

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Healthcare Management
Health Care Reform
Operations Management
Strategic Planning
Medicare/Medicaid Reimbursement
Health Insurance Exchanges
Health Insurance
Business Strategy
Health Plan Operations
Accountable Care
Health Information Exchange
Health Care Systems
Hospitals
Long-term Care
Behavioral Health
Process Improvement
Medicare
Medicaid
Performance Management
Organizational Design

Education

Investments

Octave

Series B

Total Funding: $150M

Cortica

Series D

Total Funding: $75M

Intus Care

Series A

Total Funding: $17M

Somatus

Series C

Total Funding: $400M

Lark

Series D

Total Funding: $180M

Vesta Healthcare

Series C

Total Funding: $110M

Ready

Series B

Total Funding: $130M

RubiconMD

Series C

Total Funding: $46M

Work Experience

ConcertoCare

2021

  • Chairman & CEO

    2021

Deerfield Management

2019

  • Operating Partner, Health Care Services & Technology

    2021

  • Partner, Healthcare Services & Technology

    2019 - 2021

Cardiovascular Associates of America

2023

  • Board Observer

    2023

Cortica

2023

  • Investor

    2023

Somatus

2020

  • Investor & Board Member

    2020

University of Pennsylvania School of Medicine

2019

  • Adjunct Professor

    2019

Vesta Healthcare

2020 - 2023

  • Investor & Board Observer

    2020 - 2023

myLaurel

2020 - 2023

  • Investor

    2020 - 2023

Springtide Child Development

2020 - 2023

  • Investor and Board Member

    2020 - 2023

    Exited to Cortica.

Novocardia

2020 - 2023

  • Co-founder and Board Member

    2020 - 2023

    Exited to Cardiovascular Associates of America (Acronym: CVAUSA).